TD Cowen Trims Acadia Healthcare (NASDAQ:ACHC) Target Price to $91.00

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) had its price objective cut by investment analysts at TD Cowen from $101.00 to $91.00 in a report released on Friday, Benzinga reports. The brokerage presently has a "buy" rating on the stock. TD Cowen's target price suggests a potential upside of 37.15% from the stock's previous close.

A number of other analysts have also commented on the company. TheStreet raised Acadia Healthcare from a "c" rating to a "b-" rating in a research note on Monday, March 4th. Barclays decreased their price target on shares of Acadia Healthcare from $91.00 to $89.00 and set an "overweight" rating on the stock in a research note on Wednesday. Cantor Fitzgerald reissued a "neutral" rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, March 5th. Mizuho decreased their target price on shares of Acadia Healthcare from $84.00 to $70.00 and set a "neutral" rating on the stock in a research report on Friday, May 3rd. Finally, Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a "sell" rating to a "hold" rating and set a $70.00 price target for the company in a report on Thursday, April 25th. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $87.56.

Acadia Healthcare Price Performance

NASDAQ:ACHC traded down $0.28 during mid-day trading on Friday, hitting $66.35. 704,481 shares of the company's stock traded hands, compared to its average volume of 667,199. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.27 and a current ratio of 1.27. The company has a market cap of $6.16 billion, a PE ratio of -473.89, a price-to-earnings-growth ratio of 2.04 and a beta of 1.31. The firm's 50 day simple moving average is $73.65 and its 200 day simple moving average is $77.10. Acadia Healthcare has a 1 year low of $64.74 and a 1 year high of $87.77.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Thursday, May 2nd. The company reported $0.84 earnings per share for the quarter, topping analysts' consensus estimates of $0.80 by $0.04. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The business had revenue of $768.10 million during the quarter, compared to analysts' expectations of $779.20 million. During the same period last year, the company posted $0.75 EPS. The company's revenue was up 9.1% on a year-over-year basis. Sell-side analysts expect that Acadia Healthcare will post 3.55 EPS for the current year.

Insider Activity

In related news, Director Wade D. Miquelon sold 2,203 shares of the stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now directly owns 46,074 shares of the company's stock, valued at approximately $3,934,258.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 2.00% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the business. GAMMA Investing LLC acquired a new stake in shares of Acadia Healthcare in the fourth quarter worth $26,000. Headlands Technologies LLC acquired a new stake in Acadia Healthcare in the 3rd quarter valued at $25,000. Mather Group LLC. purchased a new position in Acadia Healthcare in the first quarter valued at about $48,000. Fifth Third Bancorp lifted its stake in shares of Acadia Healthcare by 25.5% during the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company's stock worth $52,000 after purchasing an additional 136 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new position in shares of Acadia Healthcare during the third quarter worth about $96,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.